Advances in biomarker development are revolutionizing the way we study, diagnose and treat disease. This volume discusses the advances in biomarker technologies and biomarker development for brain disorders, as well as the logistical, regulatory and funding challenges experienced by scientists working on clinical trials for biomarkers.